Beximco Pharmaceuticals Ltd. Reg. Shs (GDRs RegS)/1 BT 10
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
0.49%
Market Cap
-
P/E Ratio (e)
0.00
Dividend Yield (e)
3.59 %
Earnings per Share (e)
0.00 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.41 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:56:58 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.41 | 0.41 |
| PREV. DAY'S PRICE | 0.41 | (06/02) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | 0.79 (01/15) | 0.37 (07/07) |
Key Figures (in EUR)
| 2027e | 2026e | 2025e | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | - | - | 0.05 | 0.11 | 0.10 |
| DIVIDENDS PER SHARE | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| DIVIDEND YIELD IN % | - | - | - | 5.48 % | 5.87 % |
| DIVIDEND GROWTH IN % | - | - | - | 3.85 % | -10.09 % |
| PRICE - EARNINGS RATIO | - | - | 9.77 | 4.16 | 4.26 |
| PRICE - BOOK RATIO | - | - | - | 0.54 | 0.50 |
| PRICE - SALES RATIO | - | - | - | 0.55 | 0.50 |
| PRICE - CASH FLOW RATIO | - | - | - | 2.90 | 3.23 |
Master Data
| WKN | A0ETTX |
| ISIN | US0885792061 |
| SYMBOL | R2WA |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | BEXIMCO PHARMA.GDR REGS 1 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -0.97 % | -12.77 % | -20.39 % | -8.89 % | -0.49 % | -3.76 % | -53.93 % | -8.48 % |
| HIGH | 0.41 | 0.49 | 0.52 | 0.79 | 0.79 | 0.79 | 1.44 | 0.79 |
| LOW | 0.38 | 0.38 | 0.38 | 0.38 | 0.37 | 0.23 | 0.23 | 0.38 |
Dividend
per share
Company profile
Beximco Pharmaceuticals PLC engages in the business of manufacturing and marketing generic pharmaceuticals formulation products covering a wide range of therapeutic categories. Its products include solid, liquid, cream, and ointment, suppositories, metered dose inhaler, dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company was founded by Ahmed Sohail Fasihur Rahman and Ahmed Salman Fasiur Rahman in 1976 and is headquartered in Dhaka, Bangladesh.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.